New analysis of cancer cells identifies 370 targets for smarter, personalized treatments

A new, systematic analysis of cancer cells identifies 370 candidate priority drug targets across 27 cancer types, including breast, lung and ovarian cancers.

House Republicans call CDC director to testify

WASHINGTON — A House committee that has sparred with the Biden administration over its handling of the Covid-19 pandemic and the virus’ origins is delving

November 21, 2023

Tilray Cannabis Revenue Falls 13% in FY25-Q1

Tilray Brands Reports Q1 2025 Financial Results Tilray Achieves 13% Year-Over-Year Growth, Generating Record Q1 Net Revenue of $200 Million Q1 Gross Margin Increases Over

October 10, 2024

Pharmalittle: We’re reading about abortion pill access, employer coverage of GLP-1 drugs and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.